Ignazia Tusa

823 total citations
30 papers, 597 citations indexed

About

Ignazia Tusa is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Ignazia Tusa has authored 30 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Ignazia Tusa's work include Melanoma and MAPK Pathways (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Ignazia Tusa is often cited by papers focused on Melanoma and MAPK Pathways (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Ignazia Tusa collaborates with scholars based in Italy, United States and Spain. Ignazia Tusa's co-authors include Elisabetta Rovida, Persio Dello Sbarba, Maria Grazia Cipolleschi, Giulia Cheloni, Graziana Digiacomo, Nathanael S. Gray, Antonella Gozzini, Xianming Deng, Shaoguang Li and Yi Shan and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Ignazia Tusa

29 papers receiving 589 citations

Peers

Countries citing papers authored by Ignazia Tusa

Since Specialization

Citations

This map shows the geographic impact of Ignazia Tusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignazia Tusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignazia Tusa more than expected).

Fields of papers citing papers by Ignazia Tusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignazia Tusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignazia Tusa. The network helps show where Ignazia Tusa may publish in the future.

Co-authorship network of co-authors of Ignazia Tusa

This figure shows the co-authorship network connecting the top 25 collaborators of Ignazia Tusa. A scholar is included among the top collaborators of Ignazia Tusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignazia Tusa. Ignazia Tusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells 2025 ·Cellular Oncology ·Ignazia Tusa, Sinforosa Gagliardi, (unknown), (unknown), (unknown), Matteo Lulli, Barbara Stecca, Elisabetta Rovida	1
2	Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells 2025 ·Advanced Healthcare Materials ·Daniele Martella, Ignazia Tusa, (unknown), Armando Negri, (unknown), (unknown), Martina Salzano de Luna, (unknown), Camilla Parmeggiani, Elisabetta Rovida	1
3	Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 2024 ·Molecular Oncology ·(unknown), Lucia Gardini, (unknown), (unknown), Matteo Lulli, Ignazia Tusa, (unknown), (unknown), Barbara Stecca, Marco Capitanio, Elisabetta Rovida	3
4	Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma 2024 ·American Journal Of Pathology ·(unknown), (unknown), (unknown), Ignazia Tusa, Azucena Esparís‐Ogando, Atanasio Pandiella, Tania Gamberi, Barbara Stecca, Elisabetta Rovida	4
5	Sphingosine 1‐phosphate elicits a ROS‐mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 2023 ·The FASEB Journal ·(unknown), Ignazia Tusa, (unknown), (unknown), Francesca Cencetti, Silvia Vannuccini, Francesca Castiglione, Paola Bruni, Felice Petraglia, Caterina Bernacchioni, Elisabetta Rovida, Chiara Donati	8
6	Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress 2023 ·Cells ·Ignazia Tusa, (unknown), (unknown), Elisabetta Rovida	11
7	Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential 2021 ·Cancers ·(unknown), (unknown), Silvia Peppicelli, Ignazia Tusa, Giulia Cheloni, (unknown), (unknown), Alessio Biagioni, (unknown), Nathalie M. Mazure, Matteo Lulli, Elisabetta Rovida, Persio Dello Sbarba	6
8	Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21 2021 ·Cancer Research ·(unknown), (unknown), Ignazia Tusa, (unknown), (unknown), (unknown), (unknown), Sinforosa Gagliardi, Matteo Lulli, Persio Dello Sbarba, Azucena Esparís‐Ogando, Atanasio Pandiella, Barbara Stecca, Elisabetta Rovida	29
9	Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 2021 ·Cellular and Molecular Gastroenterology and Hepatology ·Beatrice Foglia, Salvatore Sutti, Stefania Cannito, Chiara Rosso, Marina Maggiora, Riccardo Autelli, Erica Novo, Claudia Bocca, Gianmarco Villano, (unknown), Ramy Younes, Ignazia Tusa, Elisabetta Rovida, Patrizia Pontisso, Elisabetta Bugianesi, Emanuele Albano, Maurizio Parola	18
10	Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), Ignazia Tusa, Persio Dello Sbarba, Elisabetta Rovida	29
11	Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 2018 ·Stem Cell Reports ·Ignazia Tusa, Giulia Cheloni, (unknown), Antonella Gozzini, (unknown), Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba	20
12	ERK5 is activated by oncogenic BRAF and promotes melanoma growth 2018 ·Oncogene ·Ignazia Tusa, Sinforosa Gagliardi, (unknown), Silvia Pandolfi, Carmelo Urso, Lorenzo Borgognoni, Jinhua Wang, Xianming Deng, Nathanael S. Gray, Barbara Stecca, Elisabetta Rovida	53
13	Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine 2017 ·Blood ·Giulia Cheloni, Michele Tanturli, Ignazia Tusa, (unknown), Yi Shan, Antonella Gozzini, Frédéric Mazurier, Elisabetta Rovida, Shaoguang Li, Persio Dello Sbarba	69
14	The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma 2014 ·Gut ·Elisabetta Rovida, Giovanni Di Maira, Ignazia Tusa, Stefania Cannito, Claudia Paternostro, Nadia Navari, Elisa Vivoli, Xianming Deng, Nathanael S. Gray, Azucena Esparís‐Ogando, Ezio David, Atanasio Pandiella, Persio Dello Sbarba, Maurizio Parola, Fabio Marra	54
15	Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells 2014 ·Oncotarget ·Stefania Cannito, Cristian Turato, Claudia Paternostro, Alessandra Biasiolo, Sebastiano Colombatto, Irene Cambieri, Santina Quarta, Erica Novo, Elisabetta Morello, Gianmarco Villano, Silvano Fasolato, Tiziana Musso, Ezio David, Ignazia Tusa, Elisabetta Rovida, Riccardo Autelli, Antonina Smedile, Umberto Cillo, Patrizia Pontisso, Maurizio Parola	47
16	The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy 2014 ·Cell Cycle ·Elisabetta Rovida, Silvia Peppicelli, (unknown), Francesca Bianchini, Ignazia Tusa, Giulia Cheloni, Ilaria Marzi, Maria Grazia Cipolleschi, Lido Calorini, Persio Dello Sbarba	41
17	AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 2013 ·Cell Death and Disease ·V Barbetti, Ignazia Tusa, Maria Grazia Cipolleschi, Elisabetta Rovida, Persio Dello Sbarba	21
18	Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells 2013 ·Oncogene ·V Barbetti, Andrea Morandi, Ignazia Tusa, Graziana Digiacomo, (unknown), Ilaria Marzi, Maria Grazia Cipolleschi, Silvia Bessi, A. James Giannini, Angelo Di Leo, Persio Dello Sbarba, Elisabetta Rovida	28
19	Non-thermal effects of 2.45 GHz microwaves on spindle assembly, mitotic cells and viability of Chinese hamster V-79 cells 2011 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Michela Ballardin, Ignazia Tusa, Nunzia Fontana, Agostino Monorchio, (unknown), (unknown), Roberto Barale, Roberto Scarpato	32
20	Spontaneous and bleomycin‐induced chromosome damage in non cancer thyroid patients 2009 ·European Journal of Clinical Investigation ·Roberto Scarpato, Ignazia Tusa, Alessandro Antonelli, (unknown), Isabella Sbrana	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact